The FDA’s new commissioner Scott Gottlieb has outlined plans to make generic drugs more affordable, by preventing 'gaming' of the regulator's approval system. This is an extension of a plan to tackle ...
It has been reported that Novo Nordisk may have inadvertently allowed generics of its GLP-1 agonist semaglutide, the active ingredient in diabetes therapy Ozempic and obesity drug Wegovy, into the ...
Novo Nordisk is leaning on clinical evidence, localised pricing and partnerships as its frontline defence in India’s brutal semaglutide price war unleashed after the Danish company’s patent expired on ...
John Wilkerson is a Washington correspondent for STAT who writes about the politics of health care. He is also the author of the twice-weekly D.C. Diagnosis newsletter. Lizzy Lawrence leads STAT’s ...
The FDA approved the first generics of dapagliflozin (Farxiga) tablets for adults with type 2 diabetes, the agency announced on Tuesday. Generics of the SGLT2 inhibitor are indicated for glycemic ...
When news breaks, you need to understand what actually matters — and what to do about it. At Vox, our mission to help you make sense of the world has never been more vital. But we can’t do it on our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results